scispace - formally typeset
Journal ArticleDOI

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.

Reads0
Chats0
TLDR
When administered under supportive conditions, psilocybin occasioned experiences similar to spontaneously occurring mystical experiences, and the ability to occasion such experiences prospectively will allow rigorous scientific investigations of their causes and consequences.
Abstract
Rationale Although psilocybin has been used for centuries for religious purposes, little is known scientifically about its acute and persisting effects. Objectives This double-blind study evaluated the acute and longer-term psychological effects of a high dose of psilocybin relative to a comparison compound administered under comfortable, supportive conditions. Materials and methods The participants were hallucinogennaive adults reporting regular participation in religious or spiritual activities. Two or three sessions were conducted at 2-month intervals. Thirty volunteers received orally administered psilocybin (30 mg/70 kg) and methylphenidate hydrochloride (40 mg/70 kg) in counterbalanced order. To obscure the study design, six additional volunteers received methylphenidate in the first two sessions and unblinded psilocybin in a third session. The 8-h sessions were conducted individually. Volunteers were encouraged to close their eyes and direct their attention inward. Study monitors rated volunteers’ behavior during sessions. Volunteers completed questionnaires assessing drug effects and mystical experience immediately after and 2 months after sessions. Community observers rated changes in the volunteer’s attitudes and behavior. Results Psilocybin produced a range of acute perceptual changes, subjective experiences, and labile moods including anxiety. Psilocybin also increased measures of mystical experience. At 2 months, the volunteers rated the psilocybin experience as having substantial personal meaning and spiritual significance and attributed to the experience sustained positive changes in attitudes and behavior consistent with changes rated by community observers. Conclusions When administered under supportive conditions, psilocybin occasioned experiences similar to spontaneously occurring mystical experiences. The ability to occasion such experiences prospectively will allow rigorous scientific investigations of their causes and consequences.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

TL;DR: High-dose psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety.
Journal ArticleDOI

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

TL;DR: Psilocybin was associated with enduring anxiolytic and anti-depressant effects in patients with cancer-related psychological distress, sustained benefits in existential distress and quality of life, as well as improved attitudes towards death.
Journal ArticleDOI

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

TL;DR: This study established the feasibility and safety of administering moderate doses of psilocybin to patients with advanced-stage cancer and anxiety and revealed a positive trend toward improved mood and anxiety.
Journal ArticleDOI

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

TL;DR: Psilocybin caused a significant decrease in the positive coupling between the mPFC and PCC, which strongly imply that the subjective effects of psychedelic drugs are caused by decreased activity and connectivity in the brain's key connector hubs, enabling a state of unconstrained cognition.
Journal ArticleDOI

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

TL;DR: It is argued that the defining feature of “primary states” is elevated entropy in certain aspects of brain function, such as the repertoire of functional connectivity motifs that form and fragment across time, and that this entropy suppression furnishes normal waking consciousness with a constrained quality and associated metacognitive functions, including reality-testing and self-awareness.
References
More filters
DatasetDOI

The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form

TL;DR: A network is disclosed for automatically checking the skew and character spacing of digital tape drive systems to indicate out-of-tolerance conditions of those parameters.
Journal ArticleDOI

The Psychology of Religion: An Empirical Approach

TL;DR: The second edition of The Psychology of Religion as mentioned in this paper presents the most comprehnsive survey of the empirical literature on the psychology of religion available today, focusing on the broad interpretive and conceptual discussions of religion.
Journal ArticleDOI

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

TL;DR: This study suggests that it is unlikely that these central actions in man are a consequence of the release of norepinephrine in the brain, and suggests that these five agents share a common mode of central action.
Journal ArticleDOI

Does Spirituality Represent the Sixth Factor of Personality? Spiritual Transcendence and the Five-Factor Model

TL;DR: The Spiritual Transcendence Scale as mentioned in this paper is a measure designed to capture aspects of the individual that are independent of the qualities contained in the Five-Factor Model of Personality (FFM).
Journal ArticleDOI

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.

TL;DR: In healthy human volunteers, the psychotomimetic effects of psilocybin were blocked dose-dependently by the serotonin-2A antagonist ketanserin or the atypical antipsychotics risperidone, but were increased by the dopamine antagonist and typical antipsychotic haloperidol.
Related Papers (5)